SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001213900-21-062009
Filing Date
2021-11-24
Accepted
2021-11-24 17:15:58
Documents
93
Period of Report
2021-08-31

Document Format Files

Seq Description Document Type Size
1 ANNUAL REPORT f10k2021_oramedpharma.htm   iXBRL 10-K 1409760
2 AMENDMENT, DATED SEPTEMBER 19, 2021, TO CONSULTING AGREEMENTS BY AND BETWEEN ORA f10k2021ex10-7_oramedpharma.htm EX-10.7 12918
3 AMENDMENT, DATED SEPTEMBER 19, 2021, TO CONSULTING AGREEMENTS BY AND BETWEEN ORA f10k2021ex10-14_oramedpharma.htm EX-10.14 13144
4 EMPLOYMENT AGREEMENT, DATED JULY 25, 2021, BY AND BETWEEN THE COMPANY AND MICHAE f10k2021ex10-24_oramedpharma.htm EX-10.24 136643
5 FIRST AMENDMENT, DATED SEPTEMBER 19, 2021, TO EMPLOYMENT AGREEMENT, BY AND BETWE f10k2021ex10-26_oramedpharma.htm EX-10.26 9568
6 REPRESENTATIVE FORM OF INDEMNIFICATION AGREEMENTS BETWEEN ORAMED PHARMACEUTICALS f10k2021ex10-31_oramedpharma.htm EX-10.31 119317
7 FIRST AMENDMENT, DATED SEPTEMBER 19, 2021, TO EMPLOYMENT AGREEMENT, BY AND BETWE f10k2021ex10-33_oramedpharma.htm EX-10.33 10093
8 SUBSIDIARIES f10k2021ex21-1_oramedpharma.htm EX-21.1 2139
9 CONSENT OF KESSELMAN & KESSELMAN, INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM. f10k2021ex23-1_oramedpharma.htm EX-23.1 3580
10 CERTIFICATION f10k2021ex31-1_oramedpharma.htm EX-31.1 9942
11 CERTIFICATION f10k2021ex31-2_oramedpharma.htm EX-31.2 9943
12 CERTIFICATION f10k2021ex32-1_oramedpharma.htm EX-32.1 4706
13 CERTIFICATION f10k2021ex32-2_oramedpharma.htm EX-32.2 4487
14 GRAPHIC image_001.jpg GRAPHIC 28263
15 GRAPHIC fin_001.jpg GRAPHIC 2130
21 GRAPHIC image_002.jpg GRAPHIC 2314
  Complete submission text file 0001213900-21-062009.txt   7197770

Data Files

Seq Description Document Type Size
16 XBRL SCHEMA FILE ormp-20210831.xsd EX-101.SCH 80238
17 XBRL CALCULATION FILE ormp-20210831_cal.xml EX-101.CAL 31510
18 XBRL DEFINITION FILE ormp-20210831_def.xml EX-101.DEF 334218
19 XBRL LABEL FILE ormp-20210831_lab.xml EX-101.LAB 644946
20 XBRL PRESENTATION FILE ormp-20210831_pre.xml EX-101.PRE 345416
22 EXTRACTED XBRL INSTANCE DOCUMENT f10k2021_oramedpharma_htm.xml XML 812152
Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036
Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 646-844-1164
ORAMED PHARMACEUTICALS INC. (Filer) CIK: 0001176309 (see all company filings)

IRS No.: 980376008 | State of Incorp.: DE | Fiscal Year End: 0831
Type: 10-K | Act: 34 | File No.: 001-35813 | Film No.: 211448011
SIC: 2834 Pharmaceutical Preparations